Metabolic syndrome laboratory findings

Metabolic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Metabolic Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Dietary Therapy
Physical Activity
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Metabolic syndrome laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Metabolic syndrome laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Metabolic syndrome laboratory findings
CDC on Metabolic syndrome laboratory findings
Metabolic syndrome laboratory findings in the news
Blogs on Metabolic syndrome laboratory findings
Directions to Hospitals Treating Metabolic syndrome
Risk calculators and risk factors for Metabolic syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

The diagnosis of metabolic syndrome is mostly based on physical examination and lab tests. The diagnostic criteria of different international societies also involves consideration of lab tests like lipid profile and fasting blood glucose.

Laboratory Findings

• Blood glucose (fasting, post-prandial) and HbA1C to assess for diabetes
• Renal function tests like serum uric acid and urinary microalbumin to look for renal dysfunction. Hyperuricemia has been frequently shown to be associated with metabolic syndrome.
• Lipid profile - hypertriglyceridemia or low HDL levels to assess dyslipidemia.
• Thyroid function tests - as increased thyroid stimulating hormone (TSH) has been linked to a higher prevalence of metabolic syndrome
• Liver function tests
• Urine analysis may show hyperuricemia and microalbuminuria (correlates with an insulin resistant state)

Metabolic syndrome is a proinflammatory and prothrombotic state. Additional biomarkers that are worth measuring while evaluating metabolic syndrome include:

• ApoB
• High sensitivity CRP
• Fibrinogen
• Homocysteine

Studies have shown that elevated levels of these proinflammatory and prothrombotic biomarkers are associated with an increased risk for coronary artery disease (CAD) and type II diabetes. Hence measurement of these markers should be considered in the setting of CAD risk assessment.

If PCOS is suspected the following lab tests should be included in the management of metabolic syndrome:

• Serum testosterone
• Serum leutinizing hormone
• Serum FSH